This is consistent with data from other randomized trials targeting cardiovascular outcomes, and a 12-month Phase II randomized trial in adults with mild cognitive impairment
Clarify whether your plan covers semaglutide for type 2 diabetes only, or if it also covers prescriptions for weight management/obesity
A potential unique mechanism with GLP-1s is their impact on the brain in regards to dopamine reward pathways, says Dr Terri-Lynne South, a general practitioner specialising in obesity medicine
At first glance, it feels like the beginning of a new era
After reviewing clinical trial data, post-marketing surveillance reports, and real-world evidence across millions of prescriptions, the EMA concluded in 2024 that the available evidence does not support a causal association between GLP1 receptor agonists and suicidal or self-injurious behavior
These presentations occur in combination but also isolated: Hypoketotic hypoglycemia , sometimes resulting in convulsions, coma and brain damage, is most often seen in infancy and the early years of childhood
.webp)
